Public health experts are divided over how many people are getting long COVID-19, a potentially debilitating condition that comes after a patient has recovered from the coronavirus.
Ill effects from the condition can include fatigue, pain, neurological issues and even changes in mental health.
Initially, public health officials believed that only a small minority of people would suffer from long COVID-19. But some studies now indicate a majority of those infected with the coronavirus are experiencing long COVID-19 symptoms.
Still, estimates on the numbers of people with long COVID are all over the map.
Another study from the University of Arizona found that about 2 out of 3 people who experienced mild or moderate cases of coronavirus had long-lasting symptoms.
Other reports have been more conservative, estimating anywhere between 10 to 30 percent of those infected develop long-term symptoms. Those who experience ongoing symptoms from long COVID-19 have sometimes come to be known as COVID-19 long haulers.
One problem in figuring out how many people get long COVID-19 is defining it.
Apart from the wide range of symptoms, there is still debate over when a person is considered to have long COVID-19. Some health care authorities consider a patient to have the condition if symptoms persist after three to six weeks, while other think it should be considered on a longer basis.
Jim Heath, president and professor at the Institute for Systems Biology, is leading the Pacific Northwest consortium researching long COVID-19 as part of the National Institute of Health’s (NIH) RECOVER initiative, which is looking into the post-COVID-19 condition and potential ways of preventing and treating it.
Heath told The Hill that if one definition of long COVID-19 was being used — one in which symptoms lingered about four to six weeks after infection — then roughly half of those infected would be considered to have long COVID-19.
According to Heath, an estimate of 15 to 20 percent of coronavirus survivors experiencing long COVID-19 after six months was a reasonable “educated guess” and he added that there was evidence to support that rate of occurrence.
When reached for comment by The Hill, the NIH said initial studies have found that at least half of COVID-19 patients who were hospitalized reported “persistent weakness or fatigue” months after their recovery.
Studies on the prevalence of long COVID-19 have been “relatively few,” according to the NIH, and they have all focused on people who had symptomatic cases of COVID-19.
The NIH said numerous observational studies in both children and adults are being conducted to find potential treatments for long haulers. The agency has requested applications for new clinical trials to launch this summer to test potential ways of preventing and treating long COVID-19.
“In contrast to the wealth of prior knowledge that led to the vaccines for Sars-CoV-2 and a host of other viruses, there is much less known about what causes persistent symptoms following infectious illnesses or how to best treat them. As a consequence, there is more knowledge needed to fuel the scientific advances to come,” the NIH said.
As they grow, solid tumors surround themselves with a thick, hard-to-penetrate wall of molecular defenses. Getting drugs past that barricade is notoriously difficult. Now, scientists at UT Southwestern have developed nanoparticles that can break [...]
In an article recently published in the journal Talanta, researchers demonstrated a new approach to enable the specific detection of biomarkers in human tear by employing an aptamer-based graphene affinity nanosensor. The ability to detect [...]
Selenium (Se) is an essential element found in aquatic feeds that promotes the proper development, wellbeing, and fitness of marine animals. Selenium can be transformed into nanomaterials that are more easily accessible, absorbed, and consumed by [...]
In an article recently published in the journal Nanotechnology, researchers employed a single particle imaging method for fluorescence excitation with moderate intensity to achieve spatial resolution. Here, the semiconductor nanocrystals were accessed, whose emission lifetimes [...]
Grinding is an essential manufacturing process, yet the heat due to friction associated with the process causes damage to the part being processed. Lubrication is used to reduce friction; however, traditional petroleum-based lubricants can [...]
A team of researchers from HSE University, Skoltech, MPGU, and MISIS have developed a nanophotonic-microfluidic sensor whose potential applications include cancer detection, monitoring and treatment response assessment. Today, the device can identify gases and [...]
Researchers have made a scientific breakthrough with the development of ‘nanomachines’ that can kill cancerous cells. The research team headed by Dr Youngdo Jeong from the Center for Advanced Biomolecular Recognition at the Korea Institute of Science and Technology (KIST) has engineered [...]
A novel freeze-dissolving approach has been devised that offers greater efficiency and sustainability compared to the classic freeze-drying process to make superfine powder or nanoparticles. In the research published in the journal ACS Sustainable Chemistry & Engineering, sphere-shaped [...]
Participants wanted for study on the regulation of what future AI-driven nanomedicines should look like
Would you like to help in some research on the regulation of what future AI-driven nanomedicines should look like? If so, researchers at the University of Bristol are looking for volunteers to discuss ethical [...]
In an article recently published in the journal Applied Surface Science, the researchers synthesized green fluorescent carbon dots (G-CDs) from 3,5-diaminobenzoic acid and citric acid. The as-prepared G-CDs were used to target the nucleolus and [...]
Doxorubicin (DOX) is a powerful anti-cancer medication, and efforts have been made to design nanostructures for delivering it to cancerous cells. The nanostructures increase the cytotoxic effects of DOX on cancerous cells, while reducing the negative effects [...]
A team of Brown University researchers has developed a new responsive material that is able to release encapsulated cargo only when pathogenic bacteria are present. The material could be used to make wound dressings [...]
Novel three-drug regimen used to manage life-threatening developments. In April 2021, a 42-year-old man reached out to Brian Hill, MD, PhD, for a second opinion after being diagnosed with hairy cell leukemia following a bone [...]